Trade Mark Journal No.2026/013 27 March 2026

UK00004323444 13 January 2026 (5,44)

PROVUE LUNG

International priority date claimed: 15 August 2025 (United States of America) (99340561)

Class 5: Diagnostic kits comprised of assays and reagents for medical purposes; diagnostic kits comprised of assays and agents for testing of bodily fluids; diagnostic kits comprised of assays and reagents for cancer screening; medical diagnostic reagents and assays for testing bodily fluids; diagnostic reagents and assays for detecting antigens and viruses for medical purposes; medical diagnostic reagents and assays for cancer screening.
Class 44: Medical testing services; cancer testing and diagnostic services; medical diagnostic testing services in the field of oncology; medical services in the field of oncology.

PrognomIQ, Inc.

Representative: Abion UK Limited